From the above point of view, because ZnT8 is known to regulate hepatic insulin clearance [12], the optimization of hepatocyte-specific intracellular Zn2+ delivery systems are expected to be used for unique type 2 diabetes therapy without insulin injection. The gene discussed is SLC30A8; the disease is type 2 diabetes mellitus.